Danmedis, UAB - financials and debts

Company age: 35 y. 2 mo.

Update

Danmedis - Company finances

EUR
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 966,191 990,178 491,020 125,437 69,860 2,720
Profit before tax - - - - -110 0
Net profit 115,025 34,400 -249,574 -498 -110 0
Equity 181,629 198,775 -55,959 -56,457 -56,567 -56,567
Liabilities 220,986 222,218 401,667 368,779 157,770 61,132
Non-current assets 323,211 299,625 270,774 232,676 98,832 4,200
Current assets 79,404 121,368 74,934 79,646 2,371 365
Total assets 402,615 420,993 345,708 312,322 101,203 4,565
Taxes paid
STI taxes - - - 2,014 12,245 1,739
Social insurance contributions - - - 17,756 - -
Financial indicators
Revenue change y/y - +2.5% -50.4% -74.5% -44.3% -96.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 28.6% 8.2% -72.2% -0.2% -0.1% 0.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 63.3% 17.3% - - - -
Profit margin Net profit margin. Shows the overall profitability of the company. 11.9% 3.5% -50.8% -0.4% -0.2% 0.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - -0.2% 0.0%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.2 1.1 - - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 19,228 19,479 14,442 19,054 34,930 1,813

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Danmedis - Social security debts

From To Debt, €
2024-02-19 2024-02-19 638.48
2023-12-18 2023-12-18 308.63
2023-10-17 2023-10-22 302.33
2023-09-18 2023-09-24 726.94
2023-08-17 2023-08-20 638.07
2023-07-18 2023-07-20 637.60
2023-06-16 2023-06-21 212.42
2023-05-16 2023-05-18 373.64
2023-04-18 2023-04-24 5842.51
2023-03-16 2023-03-20 5286.07
2023-02-17 2023-02-27 5370.98
2022-12-16 2022-12-19 2137.07
2022-11-17 2022-11-18 3562.30
2022-08-23 2022-08-23 2951.74
2022-07-18 2022-07-27 4105.63
2022-06-10 2022-06-14 3.63
2022-04-01 2022-04-03 755.61
2022-01-28 2022-01-31 38.57
2022-01-18 2022-01-19 1163.82
2022-01-03 2022-01-09 751.15
2021-12-16 2021-12-20 6763.20
2021-11-23 2021-11-25 721.47
2021-11-17 2021-11-22 3541.47
2021-11-16 2021-11-16 7541.47
2021-11-09 2021-11-15 791.27
2021-11-05 2021-11-08 787.11
2021-10-28 2021-11-04 791.27
2021-10-21 2021-10-27 5757.13
2021-10-20 2021-10-20 8027.13
2021-10-18 2021-10-19 7269.18
2021-09-16 2021-10-03 735.36

Danmedis - VMI tax arrears

From To Overdue, €
2026-01-16 2026-01-22 1.8
2025-12-02 2025-12-02 118.79
2025-11-28 2025-12-01 118.61
2025-05-29 2025-06-01 18.31
2025-05-28 2025-05-28 684.8
2025-02-21 2025-03-20 2.8
2025-02-02 2025-02-10 288.92
2025-01-31 2025-02-01 288.84
2025-01-30 2025-01-30 288.6
2025-01-15 2025-01-15 309.44
2025-01-10 2025-01-14 308.33
2024-12-31 2025-01-01 3.33
2024-12-30 2024-12-30 263.12

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Danmedis, UAB, company code 172237895, is a private limited liability company engaged in the manufacture of other products of wood and articles of cork, straw and plaiting materials. In 2025, the latest financial year, revenue decreased sharply to €2.7K from €69.9K in 2024 and €125.4K in 2023, showing a sustained contraction in operating activity. The company posted a small net loss of €498 in 2023 and €110 in 2024; no net profit figure is reported for 2025. Profitability was weak in the two previous years, with margins of -0.4% and -0.2%. The balance sheet also weakened materially: total assets fell to €4.6K in 2025 from €101.2K in 2024 and €312.3K in 2023, while equity remained negative at €56.6K and liabilities stood at €61.1K. Asset turnover was 0.60x, indicating limited use of assets to generate sales. Revenue per employee was €2.7K, reflecting very low productivity in the latest year. Overall, the figures point to a very small-scale operation with sharply reduced turnover and a strained capital structure in 2025.